title: Two cases of spondylodiscitis caused by Parvimonas micra.
authors.affiliation: Department of Infectious Diseases, Wollongong Hospital, Wollongong, New South Wales, Australia.
authors.forename: S L
authors.initials: SL
authors.lastname: Jones
authors.affiliation: Department of Rheumatology, Wollongong Hospital, Wollongong, New South Wales, Australia.
authors.forename: J W
authors.initials: JW
authors.lastname: Riordan
authors.affiliation: Department of Oncology, Wollongong Hospital, Wollongong, New South Wales, Australia.
authors.forename: A L
authors.initials: AL
authors.lastname: Glasgow
authors.affiliation: South Eastern Area Laboratory Services, Wollongong Hospital, Wollongong, New South Wales, Australia.
authors.forename: J
authors.initials: J
authors.lastname: Botes
authors.affiliation: Department of Infectious Diseases, Wollongong Hospital, Wollongong, New South Wales, Australia.|Graduate School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia.
authors.forename: C S
authors.initials: CS
authors.lastname: Boutlis
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002097:C-Reactive Protein / Q000032:analysis; D019818:Clavulanic Acid / Q000627:therapeutic use; D002981:Clindamycin / Q000627:therapeutic use; D015299:Discitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D010397:Penicillanic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D010462:Peptostreptococcus / Q000302:isolation & purification*; D000078142:Tazobactam; D065093:beta-Lactamase Inhibitors / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D065093:beta-Lactamase Inhibitors; D019818:Clavulanic Acid; D002981:Clindamycin; D010397:Penicillanic Acid; D002097:C-Reactive Protein; D000078142:Tazobactam